PADDOCK LLC
GenericsPADDOCK LLC is a generic drug manufacturer focused on Immunology, Dermatology.
PADDOCK LLC's Key Drugs
PADDOCK LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PADDOCK LLC's Recent FDA Approvals
New NDA/BLA approvals for PADDOCK LLC over the last two years — novel drugs only, excluding generics and label supplements.
PADDOCK LLC's Therapeutic Areas
PADDOCK LLC's approved drugs and pipeline span 2 therapeutic areas, led by Immunology and Dermatology, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PADDOCK LLC's Top Competitors
PADDOCK LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Eli Lilly, and BAUSCH. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PADDOCK LLC Pipeline Snapshot
Active clinical trials for PADDOCK LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1983-04-08
- Latest
- 2010-06-07
- Applications
- 12